investor_presentation
Coronado Global Resources
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Mural Oncology plc presents its protein engineering capabilities and engineered cytokine programs, including nemvaleukin alfa for cancer immunotherapy. The presentation covers clinical development timelines, potential therapeutic applications across multiple tumor types, and combination therapy strategies within the ARTISTRY development program.
investor_presentation
35 Pages
Axon Enterprise
H1 FY26 Investor Presentation
investor_presentationinvestor_presentation
Smart Parking Limited
Sinclair Broadcast Group Investor Presentation — May 2022
investor_presentationinvestor_presentation
14 Pages
Sinclair Broadcast Group, Inc.
investor_presentation
Coronado Global Resources